Abstract
Presence of increased reactive oxygen species (ROS) has been observed in most high risk factors for brain tumor development. Our past study demonstrated that ROS could induce increased brain tumor cell proliferation. Growth effects of ROS may involve modifications of cellular proteins such as mitogen-activated protein kinases (MAPKs), which regulate cell proliferation. Here, we report effects of a ROS (hydrogen peroxide, H2O2) and an antioxidant (N-acetylcysteine, NAC) on MAPK activation in astrocytoma (U373-MG) cells. MAPKs are activated by phosphorylation that can be detected by Western blot analysis. The unphosphorylated/inactivated form of MAPK exhibits slower mobility on SDS-PAGE compared to the phosphorylated/activated form. Densitometric analysis was used to measure MAPK activation. Results indicate that H2O2 caused a dose and time-dependent increase in MAPK activation in astrocytoma cells. Furthermore, ROS-induced activation was almost completely suppressed by NAC. NAC also inhibited serum-induced MAPK activation indicating there may be an oxidant-sensitive component to serum-induced growth signaling. Modifications of MAPKs by H2O2 demonstrate that ROS-induced proliferation is via biochemical pathways similar to other known growth stimuli. Understanding of processes that link a proliferation signal (ROS) to cell proliferation can aid in the selection of therapy used to suppress brain tumor growth.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sun Y: Free radicals, antioxidant enzymes, and carcinogenesis. Free Rad Biol Med 8: 377-408, 1989
Remacle J, Raes M, Toussaint O, Renard P, Rao G: Low levels of reactive oxygen species as modulators of cell function. Mutation Res 316: 103-122, 1995
Warren BS, Slaga TJ: Mechanisms of inhibition of tumor progression. Basic Life Sci 61: 279-89, 1993
Frei B: Natural Antioxidants in Human Health and Disease. San Diego, Academic Press, 1994
Bongers V, de Jong J, Steen I, de Vries N, Bast A, Snow GB, Braakhuis BJM: Antioxidant-related parameters in patients treated for cancer chemoprevention with N-acetylcysteine. Eur J Cancer 31A: 921-923, 1995
Arora-Kuruganti P, Lucchessi PA, Wurster RD: Proliferation of cultured human astrocytoma cells response to an oxidant and antioxidant. J Neuro-Oncol 44(3): 213-221, 1999
Chen Q, Olashaw N, Wu J: Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protien kinase kinase activation pathway. J Biol Chem 270: 28499-28502, 1995
Brumell JH, Burkhardt AL, Bolen JB, Grinstein S: Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem 271: 1455-1461, 1996
Goldstone SD, Hunt NH: Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim Biophys Acta 1355: 353-360, 1997
Cobb MH, Hepler JE, Cheng M, Robbins D: The mitogen-activated protein kinases, ERK1 and ERK2. Sems Cancer Biol 5: 261-268, 1994
Graves JD, Campbell JS, Krebs EG: Protein serine/threonine kinases of the MAPK cascade. Annals N Y Acad Sciences 766: 320-343, 1995
Guan KL: The mitogen-activated proten kinase signal transduction pathway: from the cell surface to the nucleus. Cell Signal 6: 581-589, 1994
Stevenson MA, Pollock SS, Coleman CN, Calderwood SK: X-irradiation, phorbol esters, and H2O2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res 54: 12-15, 1994
Mordet G: MAP kinase kinase: a node connecting multiple pathways. Biol Cell 193-207, 1993
Szatrowski TP, Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991
Carmine TC, Bruchelt G, Hahn T, Niethammer D: Measurement of endogenous and TNFα-mediated H2O2 production in supernatents of SK-N-SH neuroblastoma cells with an enhanced chemiluminescence. J Biolumin Chemilumin 9: 267-272, 1994
Carter WO, Narayanan PK, Robinson JP: Intracellular hydrogen peroxide and superoxide detection in endothelial cells. J Leukocyte Biol 55: 253-258, 1994
Gopalakrishna R, Chen ZH, Gundimeda U: Modifications of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and enzyme-specific inhibitors. Methods in Enzymol 252: 132-146, 1995
Schwartz JL, Antoniades DZ, Zhao S: Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Annals N Y Acad Sciences 23: 262-285, 1993
Sozer O, Voller K, Liyanage M, Frith D, Kour G, Stabel S: Activation of c-raf by protein kinase C phosphorylation. Oncogene 7: 2259-2262, 1992
Chakraborti S, Chakraborti T: Down-regulation of protein kinase C attenuates the oxidant hydrogen peroxide-mediated activation of phospholipase A2 in pulmonary vascular smooth muscle cells. Cell Signal 7: 75-83, 1995
Rao G: Protein tyrosine kinase activity is required for oxidant-induced extracelluloar signal-regulated protein kinase activation and c-fos and c-jun expression. Cell Signal 9: 181-187, 1997
Oude Weernik PA, Verheul E, Kerkhof E, Van Veelen CW, Rijksen G: Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines. Neurosurgery 38(1): 108-13; discussion 113-114, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuruganti, P.A., Wurster, R.D. & Lucchesi, P.A. Mitogen Activated Protein Kinase Activation and Oxidant Signaling in Astrocytoma Cells. J Neurooncol 56, 109–117 (2002). https://doi.org/10.1023/A:1014530309082
Issue Date:
DOI: https://doi.org/10.1023/A:1014530309082